|
| Time/Date | Code | Headline | Source | Impact |
|---|---|---|---|---|
| 12:24 10-May-2013 | HCM | Result of AGM | RNS | -0.82% |
| 07:00 24-Apr-2013 | HCM | Global Phase III UC trial initiated with HPML-004 | RNS | +6.63% |
| 07:16 12-Apr-2013 | HCM | Nutrition Science Partners JV Approved | RNS | +3.53% |
| 07:00 09-Apr-2013 | HCM | 2012 Annual Report and Notice of AGM | RNS | +9.00% |
| 07:00 08-Apr-2013 | HCM | Data Presentations at AACR | RNS | +8.96% |
| 07:00 26-Mar-2013 | HCM | Final Results | RNS | +3.40% |
| 07:00 28-Feb-2013 | HCM | Total Voting Rights | RNS | +0.45% |
| 07:00 18-Feb-2013 | HCM | Notice of Results | RNS | +1.62% |
| 11:15 28-Jan-2013 | HCM | Holding(s) in Company | RNS | -3.14% |
| 07:00 31-Dec-2012 | HCM | Blocklisting Six Monthly Return | RNS | +6.01% |
| 07:00 28-Nov-2012 | HCM | Chi-Med and NestleŽ Health Science Joint Venture | RNS | +2.99% |
| 07:00 01-Nov-2012 | HCM | Phase I trial with EGFR inhibitor theliatinib | RNS | -0.07% |
| 07:00 08-Oct-2012 | HCM | TR1 Notification of major interest in shares | RNS | -0.24% |
| 13:42 28-Sep-2012 | HCM | Total Voting Rights | RNS | -0.40% |
| 14:16 13-Sep-2012 | HCM | Director's Shareholding | RNS | +2.78% |
| 11:21 28-Aug-2012 | HCM | Change of Nominated Adviser | RNS | -5.83% |
| 07:00 31-Jul-2012 | HCM | Interim Results | RNS | +12.81% |
| 09:08 05-Jul-2012 | HCM | Total Voting Rights | RNS | -1.97% |
| 07:00 29-Jun-2012 | HCM | Blocklisting Interim Review | RNS | -0.12% |
| 07:00 28-Jun-2012 | HCM | Notice of Results | RNS | +0.62% |
The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.
By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.
You will be redirected in five seconds.
You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.
The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.
By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.
You will be redirected in five seconds